Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement1 March
25-27,
1991
ABSTRACT
The
Development
National
Conference
Obesity brought together crinologists, psychiatrists, professionals
as well
treatment options severe obesity and of surgical
surgeons, nutritionists,
as the
for severe
to address:
obesity,
that
first
(1) patients
time
should
surgical program men, appropriate support,
(2)
considered
gastric
a multidisciplinary nutritional expertise, substantially of management veillance after consensus 1992:55:6
or bypass
(3) patients be selected
with
setting
and surgical
panel’s 1 5S-9S.
appropriate
procedures
support
statement
follows.
medical full text
Am
J
use
not
Nutr
In a 1985
National
the
including
Institutes
health
increased
risk
hypertension),
dyslipidemia, prevalences socioeconomic
define
morbidity to the
overweight
.4,n
male.
The
mass BMI
gallbladder
index
(BMI):
associated
Persons
J (‘fin Nuir
over 40 kg/m2. A BMI 100 pounds overweight
at the highest
1992:55:61
55-95.
risk ofmorbidity Printed
in USA.
severe
obesity.
to significant
comorbid
abnormalities
and
In addition, frequently
These
facts
care for those
the
undesirable
asseveral
significant psyare experienced
lend
seeking
side
urgency
to the
relieffrom
have
have
volume,
gastric
of weight loss both food aversion
determined
with
led to reports
effects
ofthis
In the past
procedures
in gastric
certainty.
effects
operation,
10 to 15 years,
been
developed;
bypass,
and
with
these
other
newer
pro-
procedures,
and malabsorption, Refinements
of results
Institute
of Diabetes
of Medical
superior
a consensus
and
is to
general
medicine,
psychiatry,
(ki-
Digestive
Applications development
1991. After 2 days of presentations consensus panel representing the
have
in such to those
pro-
seen
with
conference
and
Kidney
Disease
of the NIH March
25-27,
by experts in the field, a professional fields of surgery,
gastroenterology,
endocrinology,
and
of Research
nutrition, including
epidemiology,
representatives
from
lowest 4 million another
For making bibliographic reference to the consensus statement from this conference, it is suggested that the following format be used, with or without source abbreviations, but without author attribution: Gastrointestinal Surgery for Severe Obesity. NIH Consens Dcv ConfConsens Statement 199 1 March 25-27; 9(1).
of 40 kg/m2 is for an average and
disorders. problems
of surgical
convened
types
[weight
and
been
National
obesity means with
types reduction
and the Office
dis-
ofselected impairment.
is between 20 and 25 kg/m2. Approximately have BMI’s between 35 and 40 kg/m2, BMI’s to
as
(especially
mortality accompanying of overweight. A simple
(meters)2].
1 .5 million have roughly equivalent adult
mellitus,
obesity
the earlier operation; however, side effects sometimes do occur, and in spite of weight loss, ideal body weight is rarely attained. The time has come to evaluate the objective evidence for these new surgical therapies. To resolve questions relating to surgery for severe obesity, the
con-
established
disease
mortality ratios and psychosocial
is by the body
lograms)/height mortality Americans
diabetes
consensus
were
cardiovascular
and
and degree
(NIH)
of obesity
for
ease, increased of cancer, and Risk for proportional
ofHealth
implications
part
of metabolic
rational
highlighted
cedures
Introduction
ference,
with
cedures. Mechanisms which may include
surof the
C/in
a term
severe
by surgical procedures. obesity is unknown, and
its use has all but disappeared.
other
and
for all aspects
and (5) lifelong is a necessity. The
obesity,” with
condition.
ference
and
surgical, psychiatric, and be performed by a surgeon
adequate
assessment, therapy
be ac-
severe Patients
A 1978 NIH consensus conference on surgery for obesity considered primarily intestinal (jejunoileal) bypass, which exerts its weight-loss effects through malabsorption, decreased food intake, and possibly other mechanisms. This operation was shown to be effective in some reported series ofcases, but in many patients it was accompanied by serious complications. The 1978 con-
who are candidates for surcarefully after evaluation by
the
with
by persons
effort to provide
regiand
with
in large
form
cardiopulmonary and economic
of this
could
patients
“clinically obesity.”
for treatment basis ofsevere
is due
in the
serious
obesity
procedures
motivated
which
chosocial
in a non-
of a dietary modification
as having to “morbid
therapy directed to it, therefore, is not available. This nevertheless, is accompanied by a reduction in life cx-
sociations
and prethe panel
for severe
is preferred
pectancy,
for future
for treatment
team with medical, (4) the operation
in a clinical
therapy
be categorized
that
specific disorder,
for risks
of these therapies. and discussion by
components behavioral
and
experienced
working
seeking
restrictive
risks, should
nonsurgical
the need
can
are potential candidates The ultimate biologic
endocare
health
the evidence their findings,
be considered
well-informed
ceptable operative gical procedures
and
weighed Among
with integrated exercise, and
for
for Severe
the
evaluation by experts
the audience, a consensus panel pared their consensus statement. for the
Consensus
Surgery
obesity, the surgical treatments for selection, the efficacy and
on and epidemiological 2 days of presentations
recommended
of Health
gastroenterologists, and other
public
for severe the criteria
treatments
research Following
Institutes
on Gastrointestinal
mortality
© 1992 American
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/615S/4715377 by Boston University user on 13 April 2018
Society
for Clinical
Nutrition
6 1 5S
NIH
6 1 6S medical
literature
agreed
on answers
What
are the nonsurgical
obesity
and the public,
their
and
to the
CONSENSUS
considered
questions
that
CONFERENCE
the evidence
and
follow.
treatment consequences?
and
STATEMENT frequent
ognized stantial
options
for
sity
approaches
include
diets,
various
behavioral
to treatment
combinations
ofcinically of low-
modification,
exercise,
In addition to weight reduction tom such as hypertension, dyslipidemia,
agents. can
be treated
by usual
medical
severe
or very
obe-
low-calorie
and pharmacologic regimens, comorbid facand diabetes mellitus
methods.
Published
studies
of
approaches to the treatment of obesity include few reports or indications of efficacy in persons with clinically severe obesity. The potential efficacy of these approaches in persons with this degree of obesity, therefore, must be inferred from evidence of their efficacy in less obese persons. Nonsurgical treatment ofclinically severe obesity aims to crcate a caloric deficit sufficient to result in both permanent weight loss and reduction ofweight-related risk factors or comorbidity. The specific amount oftargeted weight loss is defined on a caseby-case basis and does not necessarily require reduction to ideal body weight. Very low-calorie diets (VLCD’s) have been widely publicized as having dramatic success in the treatment of clinically severe obesity. Typically, these diets contain 400 to 800 kilocalories per day with increased protein and minimal fat in a solid or liquid form. Significant weight reduction, for example 20 kg over 12 weeks, can be expected. However, in the absence of successful behavior modification, most patients regain their lost weight within 1 year. Thus, although VLCD’s used under close medical
medical
supervision
often
are
effective
in short-term
treatment
these diets alone
generally have not permanent weight loss. Combining a VLCD with intensive behavioral modification may be more effective than a VLCD alone for treating the severely obese patient. Although data on the use of this approach are few, some evidence suggests that initial treatment with a VLCD followed by intensive behavioral modification may result in sustained weight loss in highly motivated patients with clinically severe ofclinically severe obesity, been successful for achieving
obesity. Behavioral
surveillance.
Recent
studies
and
decrease
the motivation
for further
medical
acceptably,
a major
treatment restriction,
drawback
What are selection?
the surgical
A number
to the
nonsurgical
although
evidence
oflong-term
ommended
exercise
as a component
in promoting
ofweight-loss
and sustaining
efficacy
clinically activity
programs,
weight
treatments
or
because
practice
criteria
have of
in the early
the experimental
and
and
1990’s
advanced
and
have
Experience
with drug
disappointing.
therapy
Although
for clinically
severe
pharmacologic
studies
externally
reinforced
Gastric bypass proximal gastric bowel of varying Choosing preference
to prevent
disruption
or dilation.
procedures (see Fig 2) involve constructing a pouch whose outlet is a Y-shaped limb of small lengths (Roux-en-Y gastric bypass).
between these and consideration
procedures involves the surgeon’s of the patient’s eating habits. The
of
has
with
an-
orexigenic drugs suggest short-term benefit, prolonged and sustamed weight loss has not been proved with these agents. Drugs such as amphetamines and thyroid derivatives are unsafe and unapproved. Medical
are usually rhythmias
avoided
complications
treatable.
of rapid
weight
loss
may
occur
and
abnormalities and cardiac axduring administration of VLCD’s generally can be or corrected by the inclusion of high-quality protein
Electrolyte
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/615S/4715377 by Boston University user on 13 April 2018
beyond
Vertical banded gastroplasty (see Fig 1) and related techniques consist of constructing a small pouch with a restricted outlet along the lesser curvature of the stomach. The outlet may be
been
obesity
as
procedures
stage.
established. been
discarded
Two
of
the role
is
for
been tried complications.
severe is rec-
loss has never
approach
body
of operations
inefficacious dominate
reduced
is a therapeutic
this more conservative approach in persons with obesity is lacking. Although increased physical
therapy.
weight in most patients. The not be excluded that the highly motivated patient can achieve sustained weight reduction by a combination ofsupervised low-calorie diets and prolonged, intensive behavior modification therapy. failure to maintain possibility should
the assumption that habitual eating haviors must be relearned to promote Behavioral ofcaloric
rec-
Limited success has been achieved by various techniques that include medically supervised dieting and intensive behavior modification. During such a treatment program, comorbidity factors such as hypertension, dyslipidemia, and diabetes mellitus can be treated by conventional medical therapy in the patient with clinically severe obesity. Although weight may be reduced
approach based on and physical activity belong-term weight change. also can be combined with a lesser degree
modification
have
may be associated with a subAlthough there are no specific
complications of behavior therapy, failure to achieve sustained weight reduction may heighten the patient’s sense of personal
severe
failure Nonsurgical
physician
that rapid weight loss incidence of gallstones.
FIG
I . Vertical
banded
gastroplasty.
NIH
CONSENSUS
CONFERENCE
6 1 7S
STATEMENT
sleep apnea,
Pickwickian
myopathy)
or severe
syndrome,
diabetes
and obesity-related
mellitus.
Other
cardio-
possible
indications
for patients with BMI’s between 35 and 40 include obesity-induced physica/problems interfering with lifestyle (e.g., joint disease treatable but for the obesity, or body size problems precluding
or severely
interfering
with
employment,
family
function,
and ambulation). Children and adolescents have not been sufficiently studied to allow a recommendation for surgery for them even in the face of obesity associated with BMI over 40.
What are the for obesity?
efficacy
and
risks
of surgical
treatments
Issues ofefficacy and risk in bariatric surgical procedures must be viewed in light of the fact that severe obesity is a chronic intractable
FIG 2. Roux-en-Y
gastric
bypass.
must somewhat greater must be balanced
weight
against
disorder;
any
therapeutic
program
must,
therefore,
be lifelong. While definitive therapy for severe obesity is not available, the surgical procedures in use can induce substantial weight loss, and this, in turn, may ameliorate comorbid conditions. Since short- and intermediate-term effects observed in several studies may relate to long-term benefits, further application and investigation ofthese operations arejustified. It must be kept in mind, however, that long-term results are of critical importance and
loss after the gastric bypass procedure its higher risk ofnutritional deficiencies,
especially of micronutrients. Biliary-pancreatic bypass
includes a gastric restriction and dijuice into the distal ileum. Experience in the United States is limited.
be delineated.
Ofspecial
note,
many
patient
to date are not representative ofthe distribution and cultural factors, and socioeconomic status verely obese population. Efficacy
with the procedure
Weight loss. The two major types of present operations for severe obesity are vertical banded gastroplasty and Roux-en-Y gastric bypass. The success rate for weight loss has been reported to be slightly higher with the Roux-en-Y operation. Substantial weight loss generally occurs, with the weight nadir occurring in
selection
These surgical procedures are major operations with shortand long-term complications, some ofwhich remain to be completely elucidated. There are insufficient data on which to base recommendations for patient selection using objective clinical features alone. However, while data accumulate, it may be possible in certain cases to consider surgery on the basis of limited information from the uncontrolled or short-term followup studies available. A decision to use surgery requires assessing the risk-benefit ratio in each case. Those patients judged by expe-
rienced
clinicians
to have
a low probability
ofsuccess
with
non-
in established weight control programs or reluctance by the patient to enter such a program, may be considered for surgery. A gastric restrictive or bypass procedure should be considered only for well-informed and motivated patients with acceptable operative risks. The patient should be able to participate in treatment and long-term followup. Patients whose BMI exceeds 40 are potential candidates for surgery if they strongly desire substantial weight loss, because obesity severely impairs the quality of their lives. They must clearly and realistically understand how their lives may change after operation. In certain instances less severely obese patients (with BMI’s surgical
measures,
between 35 and in this category
such
as demonstrated
for
40) also may be considered are patients with high-risk
as life-threatening
cardiopulmonary
example
by failures
for surgery.
comorbid problems
Included
conditions (e.g. severe
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/615S/4715377 by Boston University user on 13 April 2018
18 to 24 months.
treatmentsfor
studied
of race, ethnic among the se-
verts bile and pancreatic
Patient
ofsurgical
cohorts
Some
regain
obesity
of weight
is common
by 2 to 5
after operation. A third operation, biliopancreatic bypass, about which there are only limited data, also has been reported to produce weight loss but with a higher frequency of metabolic years
complications.
Comorbid conditions. Weight reduction surgery has been reto improve several comorbid conditions such as sleep apnea and obesity-associated hypoventilation, glucose intolerance, frank diabetes mellitus, hypertension, and serum lipid abnormalities. Whether beneficial effects in the various metabolic ported
disorders
are
damage
heart
(e.g.
maintained renal
long
disease,
enough
stroke,
to
prevent
myocardial
end-organ
infarction
and
failure)
is not known. Psychosocial effects. Many patients report improvement in mood and other aspects of psychosocial functioning after these operative procedures. The degree to which these improvements are sustained is unknown. Risk evaluating Available
the risks in the surgical treatment ofobesity involves both perioperative and long-term complications. published series report that the immediate operative
mortality
rate
Assessing
en-Y
gastric
for both
bypass
vertical
is relatively
banded
gastroplasty
low. On the other
and
hand,
Roux-
mor-
618S
NIH
bidity
in the
dehiscence,
early
postoperative
leaks
marginal
from
ulcers,
bophlebitis
various
in the
period,
staple
line may
dilation,
obstruction),
persistent
kind
and deep throm-
be as high
as
or failure
10 percent
or
weight.
Moreover,
by a decision
of program
therapy
other problems may are pouch and distal (with or without stomal
to lose
STATEMENT
be followed
stenosis,
period, These
vomiting
cholecystitis,
CONFERENCE
infections,
stomal
problems,
more. In the later postoperative arise and may require reoperation. esophageal
i.e. wound
breakdown,
pulmonary
aggregate,
CONSENSUS
for nonsurgical
or with
if significant
therapy
a different
in a different
therapist,
comorbidities
do
not
for
exist,
no
further
or for surgical
therapy. Patients who are candidates viewed during this conference evaluation
for the surgical should be selected
by a multidisciplinary
surgical,
psychiatric,
and
team
nutritional
with
procedures carefully
access
expertise.
reafter
to medical,
Patients
should
mortality and morbidity rates with reoperation are higher than those of primary operations. In the long term, micronutrient deficiencies, particularly of vitamin B12, folate, and iron, are common after gastric bypass and must be sought and treated. Another potential result of this
advantages of each. The need for lifelong medical surveillance after surgical therapy should be made clear. With all of these considerations, the patient should be helped to arrive at a fully
operation
is the so-called
informed,
acterized
by gastrointestinal
casionally,
these
“dumping
symptoms
may
because
reduction uncertain weight
as many
and not
measures and may be troublesome Many data suggest that deficient with it a high risk of fetal damage concern
syndrome,”
distress
which
other
respond
is char-
symptoms. to conservative
ofpatients
having
weight
micro-
or macronutrient
deficiency,
or other
met-
abolic sequelae ofthese procedures, secure birth control methods should be provided for these patients during this period of weight loss. They should be informed that maternal malnutrition may impair
after
normal
these
clinical
fetal development.
surgical
care
procedures
team.
The
Women
need
increased
who
special
become
pregnant
attention
nutritional
from
the
requirements
for
energy, protein, need for weight
and specific micronutrients as well as the normal gain during pregnancy must be emphasized as part of the obstetrical management of these patients. Quality-of-life
considerations
in patients
undergoing
surgical
treatment for obesity must be considered, as there must be reorientation and adjustment to the side effects ofsurgery and the effect ofa changing body image. Euphoria can be seen in patients during the early postoperative period. Some patients, however, may experience significant late postoperative depression. Some patients have depressive symptoms that are not improved by surgically-induced
What
weight
specific
treatment Decisions clinically
loss.
recommendations
of severe on severe
what obesity
can
be made
for the
obesity? therapy
to patients
to recommend
should
depend
on their
wishes
with for out-
comes, on the physician’s judgment of the urgency of the need for therapy, and on the physician’sjudgment ofpossible options for therapy and their probable efficacy. Patients seeking therapy for the first time should be evaluated by a knowledgeable physician and provided with sufficient information on which to make a reasonable choice for therapy. In most cases, patients should first be considered for treatment in a nonsurgical program with integrated components ofa dietary regimen, appropriate exercise, and behavioral support and modification.
Possible
comorbidities
such
as hypertension
and
diabetes should be sought and treated ifnot already under treatment. The desired outcomes may vary among patients and indude such indices as a gain in the quality of life as judged by the patient, reduction ofhypertension, and amelioration of glucose intolerance. Ajudgment offailed nonsurgical therapy should
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/615S/4715377 by Boston University user on 13 April 2018
tolerate
surgery
and
decision
for surgical of the
with the physician
options
independent
A decision
with with
to explore
treatment
assessment
surgery are women ofchildbearing age. In view of the frequency and effects on fetal development of rapid loss,
unconsidered
Oc-
to the patient. nutrition in pregnancy carries or loss. This is of particular
as 80 percent
have an opportunity
that
excessive
extent
to which
of the compliance imen,
and
that
of the
be reached
the
patient
risk and
dis-
only
will
after
be able
to comply
to
adequately
There must be full discussion outcome of the surgery, of the
it will eliminate
the patient’s
will be needed
possible
and
his or her therapy.
should
the postoperative regimen. the patient of the probable
probable
advantages
concerning
therapy
probability
without
the
any previously
problems,
in the postoperative
complications
from
the
reg-
surgery,
both
short- and long-term. Women with reproductive potential would be well advised to avoid pregnancy until weight has stabilized postoperatively and potential micronutrient deficiencies have been identified and treated. The operation should be carried out by a surgeon substantially experienced with the appropriate procedures and working in a clinical setting with adequate support for all aspects of perioperative tional
management counseling,
and and
assessment. surveillance
Postoperative should continue
care, for
nutrian in-
definitely long period. The surveillance should include the monitoring of indices of inadequate nutrition and of amelioration
of any preoperative disorders such as diabetes, hypertension, and dyslipidemia. The monitoring should include not only indices of macronutrients but also of mineral and vitamin nutrition. What are the research, and
future directions epidemiological
for basic evaluation
science, clinical of therapy?
The panel recognized the need to develop safe and effective means to treat patients with clinically severe obesity. In the view ofthe panel, none ofthe available therapies, including surgery, has been adequately evaluated. For this reason, it is recommended that centers be developed that can manage patients with clinically
severe
at the same tigations
with
involve a team as epidemiology, enterology,
obesity,
time,
using
can enter
long-term
that
a multidisciplinary
these
patients
followup.
includes nutrition,
The
approach,
into controlled research
and,
inves-
will
need
to
professionals trained in fields such surgery, general medicine, gastro-
cardiovascular-pulmonary
medicine,
psychiatry,
and
endocrinology. Only if in-depth investigations are carried out over long periods will needed information be obtained to care for obese patients more effectively in the future. A series of issues arose during the conference that need additional investigation. These issues include the following: 1 The balance of efficacy and risk between surgical treatment and nontreatment or alternative treatments of severe obesity .
is difficult
to evaluate
are studies
that
with
use well-defined
available
groups
information.
of subjects
Lacking
and stan-
NIH dard
protocols,
comes. sufficiently ical trials 2.
with
adequate
Nevertheless, encouraging that address
procedures
are
A better
vocabulary
power
the current
clearly outcomes.
can
of any 4.
serve form
Various
terms
related These
and
The
and
were
risks
of surgical (ie,
6.
are
of
altered
of
enhanced
produces food
metabolism)
deserve
effects
therapy
of surgical fetuses after
and such
statistical more need
by these
treatment whether
7. One case
were
must of surgical
assessments
effective
of mothers
efficacy
The present of comorbidity
compare
for women
8.
is urgently
of outcomes.
alternate and
forms evaluated.
of weight-reduction Specifically,
group ment
to get
be determined. results
best
to maintain
weight
re-
the
identified:
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/615S/4715377 by Boston University user on 13 April 2018
therapy.
therapy
needs
long-term exploration. long-term
drug
further
therapy Especially safety, and
in combination.
in evaluating therapy
the current
is the
practice to the
lack
reports
levels
approach
is to compare same patient’s
oflong-term
effects
for evaluating
of morbidity
and
surgical
mortality
of
of standards
for
postoperative own preop-
Although this approach may give some on short-term effects of surgical therapy, for evaluation
socioecode-
of drugs
in surgical
An alternative
their
psychologist,
approach.
how
drug
series
in various
on
and
key problems
erative status. information
proce-
age, ethnicity, fat distribution.
be-
populations
clinical
for pharmacologic
ofthe
comparison. indicators
whereby
surgical
be defined
it is safe
operations
to be developed
needs
should
gender, and
reporting
for clearer
In addition,
of mechanisms
reduced
of overweight
evaluation. The possibility that can be used successfully deserves important are efficacy of therapy,
obesity.
nutrients,
on
for
exercise
is a need to determine that are most effective
of physician,
behavioral
is needed
havior therapy, c. The potential
com-
of obesity.
treatment
Research
subgroups roles
techniques and
duction for a long term, with clarification of the roles of reduced caloric intake and increased energy expenditure (e.g., exercise). Consideration should be given to use of combined approaches, for example, low-calorie diets, be-
effects
definition
various
insufficient of surgical
veloping
following
in the
is required
for severe
surgical
is needed
factors
pregnant
therapy
therapy
intake,
subgroups stratified for nomic status, comorbidity,
needed
dietitian
maintenance,
for better
malabsorption
investigation
dures. c. The effects
Better
and b.
for
complications
identified
whereby
decreased
comorbidity
e.
the
investigation.
Further
The
to define
long-term
weight
in eating
and
terms
be compared
long-term
issues
reduction
further
should
loss,
mechanisms
aversion,
d.
obesity
behavioral
changes
needed
communication
the
effective
long-term
haviors is needed. Further, there the types of behavioral strategies
especially
ofsevere
to evaluate
in secondary
specific
weight
b.
weight
of more
producing
are
dinsurgical
critically
improve
history
procedures
rates,
the efficacy a.
a. Development
out-
series
of therapy.
improvement
5. Several
are
to obesity, will
as a baseline
surgical
plication
case
in treating
nomenclature
between investigators. 3. A definition ofthe natural that
long-term
from
6 1 9S
STATEMENT
in order. and
defining
to define
reports
CONFERENCE
to indicate that well-organized the critical issues surrounding
now
to define
CONSENSUS
and
useful it is
of survival.
therapy in the
is to
surgical
with an appropriate comparison group. The establishofa meaningful comparison group presents a challenge
to future research. Evaluation of the psychosocial changes that occur during weight reduction is needed. Standardized, reliable, and valid questionnaires and structured interviews should be developed to evaluate the patient’s expectations about changes and the psychosocial changes they actually experience during weight loss and maintenance.